CCTG BR34: A Randomized Phase 2 Trial of Durvalumab and Tremelimumab With or Without Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Natasha B. Leighl, Scott A. Laurie, Glenwood Goss, Brett Hughes, Martin R. Stockler, Ming‐Sound Tsao, David Hwang, Phillipe Joubert, Swati Kulkarni, Normand Blais, Anil A. Joy, Mihaela Mates, Punam Rana, Sunil Kumar Yadav, Craig Underhill, Christopher Lee, Penelope A. Bradbury, Andrea Hiltz, Janet Dancey, Keyue Ding, Francisco Vera-Badillo